Kenvue Inc. Common Stock · Transaction Aug 5, 2026 · Filed Aug 10, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · KVUE
-0.23% · -$0.0400 · Vol 14.0M
Market closed · last close 4:00 PM ET · price as of 19:54:35 ET
Kenvue Inc
Consumer products
$17.18
Follow $KVUE
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $KVUE by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 2 · market closed · Markets closed · resumes Mon 9:30 ET · KVUE
MethodologyKVUE
Kenvue Inc
Fri Oct 2 · market closed · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
61/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 2 · market closed · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is KVUE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Kenvue Inc
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONSListed since
2023
Employees
22K
Country
US
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$17.33
Day high
$17.38
Day low
$17.16
Previous close
$17.22
52W high
$19.83
-13.36% from high
52W low
$14.11
54% of range
Market cap
$33.1B
P/E
18.67×
EPS
$0.9200
Beta
-0.15
Shares out
1.9B
Volume
14M
0.58× rel vol
Avg volume
24M
VWAP
$17.23
Price history computed in-house
1W
-3.48%
1M
-9.34%
3M
-13.36%
1Y
+8.67%
YTD
-0.41%
SMA 50 $18.64 · below
SMA 200 $18.03 · below
52W position 54%
KVUE overview
Related filings and maps
Public disclosures
Congress activity in KVUE
Official filing ↗
Kenvue Inc. Common Stock · Transaction Jul 17, 2026 · Filed Sep 4, 2026 · $1,001 to $15,000
Kenvue Inc. Common Stock · Transaction Jun 16, 2026 · Filed Jul 2, 2026 · $1,001 to $15,000
Kenvue Inc. Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
Kenvue Inc. Common Stock · Transaction Mar 17, 2026 · Filed Apr 3, 2026 · $15,001 to $50,000
Federal contracts
KVUE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KVUE in this window.
Lobbying spend
KVUE lobbying filings, year to date.
Registered lobbying filings matched to Kenvue Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KVUE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for KVUE.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.